CA-A Cancer Journal for Clinicians

Papers
(The median citation count of CA-A Cancer Journal for Clinicians is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries53206
Cancer Statistics, 202111472
Cancer statistics, 202210121
Cancer statistics, 20235166
Cancer treatment and survivorship statistics, 2022961
Management of glioblastoma: State of the art and future directions950
Current treatment and recent progress in gastric cancer768
Breast Cancer Statistics, 2022677
Cancer statistics for adolescents and young adults, 2020579
Treatment of muscle‐invasive and advanced bladder cancer in 2020495
Colorectal cancer statistics, 2023491
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society462
Brain and other central nervous system tumor statistics, 2021420
Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations363
American Cancer Society guideline for diet and physical activity for cancer prevention346
Metabolomics in cancer research and emerging applications in clinical oncology281
Cancer statistics for African American/Black People 2022243
American Cancer Society nutrition and physical activity guideline for cancer survivors241
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma235
Older adult participation in cancer clinical trials: A systematic review of barriers and interventions228
Cancer statistics for the US Hispanic/Latino population, 2021180
Clinical management of metastatic colorectal cancer in the era of precision medicine172
Cancer statistics, 2024162
150
Integrative oncology: Addressing the global challenges of cancer prevention and treatment146
Radiation therapy‐associated toxicity: Etiology, management, and prevention141
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies136
Molecular imaging in oncology: Current impact and future directions117
A systematic review of rehabilitation and exercise recommendations in oncology guidelines112
American Cancer Society's report on the status of cancer disparities in the United States, 2021108
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions100
Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation92
An update on the immune landscape in lung and head and neck cancers91
86
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians86
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach81
Onconephrology: The intersections between the kidney and cancer76
Intermittent fasting in the prevention and treatment of cancer75
Evolving standards of care and new challenges in the management of HER2‐positive breast cancer74
73
Cervical cancer prevention and control in women living with human immunodeficiency virus72
Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention–sponsored Summit68
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward68
The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer67
Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review63
The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies60
Blueprint for cancer research: Critical gaps and opportunities51
Cancer epigenetics in clinical practice50
Recent progress in the treatment of cancer in children46
Climate change and cancer46
44
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians43
Cancer statistics forAmericanIndian andAlaskaNative individuals, 2022: Including increasing disparities in early onset colorectal cancer42
Sexual health among adolescent and young adult cancer survivors: A scoping review from the Children's Oncology Group Adolescent and Young Adult Oncology Discipline Committee41
An overview of real‐world data sources for oncology and considerations for research40
The contemporary management of cancers of the sinonasal tract in adults40
Current and future cancer staging after neoadjuvant treatment for solid tumors37
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions37
Critical care management of chimeric antigen receptor T‐cell therapy recipients32
Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature31
Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice28
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer27
Addressing distress management challenges: Recommendations from the consensus panel of the American Psychosocial Oncology Society and the Association of Oncology Social Work27
Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement26
26
Erratum to “Cancer statistics, 2021”25
Time to add screening for financial hardship as a quality measure?25
The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future24
Radiotheranostics in oncology: Making precision medicine possible22
Oncologic emergencies and urgencies: A comprehensive review21
Screening for lung cancer: 2023 guideline update from the American Cancer Society20
20
How can hospitals change practice to better implement smoking cessation interventions? A systematic review19
Health insurance status and cancer stage at diagnosis and survival in the United States18
Genetic testing in prostate cancer management: Considerations informing primary care16
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer16
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma16
Hematology and oncology clinical care during the coronavirus disease 2019 pandemic16
16
Interventional gastroenterology in oncology15
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries14
13
Examining the interrelationships between mindfulness‐based interventions, depression, inflammation, and cancer survival12
Locally advanced rectal adenocarcinoma: Treatment sequences, intensification, and rectal organ preservation12
12
Clinician communication strategies associated with increased uptake of the human papillomavirus (HPV) vaccine: A systematic review12
Nutrition and Physical Activity Guideline for Cancer Survivors10
Breast cancer recurrence risk can remain for 10 to 32 years10
Planning for post‐pandemic cancer care delivery: Recovery or opportunity for redesign?9
Social determinants of health and US cancer screening interventions: A systematic review9
Multidisciplinary considerations in the treatment of triple‐negative breast cancer9
Current treatment and future directions in the management of anal cancer9
Immunosurveillance in clinical cancer management8
Cancer risk among World Trade Center rescue and recovery workers: A review8
Translating energy balance research from the bench to the clinic to the community: Parallel animal‐human studies in cancer8
Female erectile tissues and sexual dysfunction after pelvic radiotherapy: A scoping review8
Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best‐practice guide8
8
Rates of advanced prostate cancer continue to increase7
The social media cancer misinformation conundrum7
Cancer treatment delays caused by the COVID‐19 pandemic may not hinder outcomes6
Multidisciplinary considerations in the maintenance treatment of poly(ADP‐ribose) polymerase inhibitors for homologous recombination‐proficient, advanced‐stage epithelial ovarian cancer6
Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer6
Opportunistic salpingectomy may reduce ovarian cancer risk6
Pairing smoking cessation with lung cancer screening may save lives6
Screening for cervical cancer6
Fecal microbiota transplants may aid melanoma immunotherapy resistance6
6
American Cancer Society’s report on the status of cancer disparities in the United States, 20235
The evolving landscape of salivary gland tumors5
Modern developments in germline pharmacogenomics for oncology prescribing5
Medicaid expansion increases survival for patients with cancer5
5
The case for catch‐up human papillomavirus vaccination in at‐risk populations: Rural communities and survivors of pediatric and young adult cancers4
4
Cancer care for people with dementia: Literature overview and recommendations for practice and research4
4
It's not a mystery, it's in the history: Multidisciplinary management of multiple endocrine neoplasia type 14
4
Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer4
Locally advanced lung cancer4
0.02675199508667